West Nile - InnovatorThis page contains information on West Nile - Innovator for veterinary use.
The information provided typically includes the following:
- West Nile - Innovator Indications
- Warnings and cautions for West Nile - Innovator
- Direction and dosage information for West Nile - Innovator
West Nile - InnovatorThis treatment applies to the following species:
West Nile Virus Vaccine
West Nile - Innovator Indications
For intramuscular vaccination of healthy horses 10 months of age or older as an aid in the prevention of viremia caused by West Nile Virus.
EFFICACY: Efficacy was demonstrated in 10-month-old horses that received two doses of the vaccine and were challenged one year post-vaccination with West Nile Virus. The vaccine protected 95% of the vaccinates against viremia, while 82% of the controls were viremic.
SAFETY: Field safety testing has demonstrated that this product is safe for use in horses 3 months of age or older. Efficacy has not been established in foals 3 months of age.
DOSE: Inject one 1 mL dose intramuscularly using aseptic technique. Administer a second 1 mL dose 3 to 6 weeks after the first dose. Revaccinate annually with one 1 mL dose.
West Nile - Innovator Caution
Store in the dark at 2° to 7°C (35° to 45°F). AVOID FREEZING. SHAKE WELL. Use entire contents when first opened. In some instances, transient local reactions may occur at the injection site. Do not vaccinate within 21 days before slaughter. In case of anaphylactoid reaction, administer epinephrine.
Thimerosal, neomycin and polymyxin B added as preservatives.
For Veterinary Use Only
U.S. Vet. License No. 190
Zoetis Inc., Kalamazoo, MI 49007, USA
333 PORTAGE STREET, KALAMAZOO, MI, 49007
|Every effort has been made to ensure the accuracy of the West Nile - Innovator information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2017 North American Compendiums. Updated: 2017-07-10